Attention-deficit/hyperactivity disorder has long been treated mainly with stimulants, and the handful of non-stimulant ...

The FDA has approved Simtriyo, a nonstimulant daily pill for ADHD in children, teens, and adults. Here’s more on potential ...

The U.S. Food and Drug Administration has approved Simtriyo (centanafadine) for the treatment of ...

New research reveals ADHD isn't one-size-fits-all — covering social media's specific role, why medication rarely 'stops ...

Understood reports that the FDA has approved Simtriyo, a new ADHD medication targeting dopamine, norepinephrine, and serotonin, promising fewer side effects.

The Food and Drug Administration (FDA) approved a new "first-in-class" medication to help manage attention deficit ...

Are ADHD medications overprescribed in kids? Are too many kids taking ADHD medication? Understood examines the question of whether stimulant medications for ADHD are overprescribed, which has been ...

Once believed to be a condition that children outgrow, attention deficit hyperactivity disorder (ADHD) is now recognized as a ...

ADHD symptoms can sometimes overshadow autism traits, making them harder to recognize. Treatment may change that balance.

Amid rising diagnoses, a growing number of kids are getting prescriptions for ADHD medications — but the administered doses aren’t always accurate. Medication ...

For decades, ADHD was viewed as a childhood condition that mostly affected boys. Researchers now know ADHD manifests ...